论文信息 - Phase 1 Study of Adct-301 (Camidanlumab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody Drug Conjugate, in Relapsed/Refractory Classical Hodgkin Lymphoma - 字舞流文

Phase 1 Study of Adct-301 (Camidanlumab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody Drug Conjugate, in Relapsed/Refractory Classical Hodgkin Lymphoma

J. Radford | S. Horwitz | J. Wuerthner | J. Boni | A. Davies | A. Spira | T. Menne | P. Caimi | F. Samaniego | G. Collins | M. Hamadani | J. Feingold | H. Cruz | Shui He